These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2344973)

  • 1. Low-grade stromal sarcoma: DNA flow cytometric analysis and estrogen progesterone receptor data.
    Dunton CJ; Kelsten ML; Brooks SE; Viglione MJ; Carlson JA; Mikuta JJ
    Gynecol Oncol; 1990 May; 37(2):268-75. PubMed ID: 2344973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine sarcoma: steroid receptors and response to hormonal therapy.
    Wade K; Quinn MA; Hammond I; Williams K; Cauchi M
    Gynecol Oncol; 1990 Dec; 39(3):364-7. PubMed ID: 2258084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer.
    Chambers JT; MacLusky N; Eisenfield A; Kohorn EI; Lawrence R; Schwartz PE
    Gynecol Oncol; 1988 Sep; 31(1):65-81. PubMed ID: 3410357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid receptors in endolymphatic stromal myosis.
    Baker VV; Walton LA; Fowler WC; Currie JL
    Obstet Gynecol; 1984 Mar; 63(3 Suppl):72S-74S. PubMed ID: 6700885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase cytochrome P450 and estrogen and progesterone receptors in uterine sarcomas: correlation with clinical parameters.
    Kitaoka Y; Kitawaki J; Koshiba H; Inoue S; Ishihara H; Teramoto M; Honjo H
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):183-9. PubMed ID: 15084350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.
    Kleine W; Maier T; Geyer H; Pfleiderer A
    Gynecol Oncol; 1990 Jul; 38(1):59-65. PubMed ID: 2141316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine aspects of human uterine sarcoma: a preliminary study.
    Tseng L; Tseng JK; Mann WJ; Chumas JC; Stone ML; Mazella J; Sun B; Amalfitano TG; Wallach RC
    Am J Obstet Gynecol; 1986 Jul; 155(1):95-101. PubMed ID: 2942037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Sep; 29(9):924-31. PubMed ID: 9744308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine stromal neoplasms: a clinicopathologic and DNA flow cytometric correlation.
    el-Naggar AK; Abdul-Karim FW; Silva EG; McLemore D; Garnsey L
    Hum Pathol; 1991 Sep; 22(9):897-903. PubMed ID: 1916750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
    Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E
    Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases.
    Omi M; Tonooka A; Chiba T; Tanaka Y; Fusegi A; Aoki Y; Nomura H; Kanao H; Takazawa Y
    Diagn Pathol; 2020 Sep; 15(1):119. PubMed ID: 32972432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution and prognostic implications of steroid receptors in endometrial carcinomas.
    Utaaker E; Iversen OE; Skaarland E
    Gynecol Oncol; 1987 Sep; 28(1):89-100. PubMed ID: 3653774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen Receptor Expression in Endometrial Stromal Sarcoma: Correlation With Clinicopathologic Features.
    Roy M; Kumar S; Bhatla N; Ray MD; Kumar L; Jain D; Phulware R; Mathur SR
    Int J Gynecol Pathol; 2017 Sep; 36(5):420-427. PubMed ID: 28114189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoplasms of endometrial stroma: histopathologic and flow cytometric analysis with clinical correlation.
    August CZ; Bauer KD; Lurain J; Murad T
    Hum Pathol; 1989 Mar; 20(3):232-7. PubMed ID: 2722173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel flow cytometric steroid hormone receptor assay for paraffin-embedded breast carcinomas: an objective quantification of the steroid hormone receptors and direct correlation to ploidy status and proliferative capacity in a single-tube assay.
    Leers MP; Schutte B; Theunissen PH; Ramaekers FC; Nap M
    Hum Pathol; 2000 May; 31(5):584-92. PubMed ID: 10836298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors.
    Katz L; Merino MJ; Sakamoto H; Schwartz PE
    Gynecol Oncol; 1987 Jan; 26(1):87-97. PubMed ID: 3792939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on estrogen and progesterone receptors in endometriosis and adenomyosis].
    Peng Z; Liu S; He B; Xi M; Cao Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):290-2. PubMed ID: 8288201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is endocrine status relevant to treatment planning in patients with gynaecological cancer?
    Quinn MA
    Aust N Z J Obstet Gynaecol; 1984 May; 24(2):153-7. PubMed ID: 6594131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.